Invesco Ltd. Recursion Pharmaceuticals, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 115,551 shares of RXRX stock, worth $836,589. This represents 0.0% of its overall portfolio holdings.

Number of Shares

115,551

Previous 108,267 6.73%

Holding current value

$836,589

Previous $812,000 6.28%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$5.92 - $8.6 $43,121 - $62,642	7,284 Added 6.73%	115,551 $761,000
Q2 2024 Aug 13, 2024	BUY	$7.35 - $10.05 $71,317 - $97,515	9,703 Added 9.84%	108,267 $812,000
Q1 2024 May 14, 2024	SELL	$9.13 - $15.52 $203,799 - $346,437	-22,322 Reduced 18.47%	98,564 $982,000
Q4 2023 Feb 12, 2024	BUY	$5.09 - $10.79 $70,221 - $148,858	13,796 Added 12.88%	120,886 $1.19 Million
Q3 2023 Nov 13, 2023	BUY	$6.59 - $15.86 $3,822 - $9,198	580 Added 0.54%	107,090 $819,000
Q2 2023 Aug 11, 2023	SELL	$4.56 - $9.94 $57,934 - $126,287	-12,705 Reduced 10.66%	106,510 $795,000
Q1 2023 May 12, 2023	BUY	$6.42 - $9.64 $478,899 - $719,095	74,595 Added 167.18%	119,215 $795,000
Q4 2022 Feb 13, 2023	SELL	$7.16 - $12.7 $2,377 - $4,216	-332 Reduced 0.74%	44,620 $344,000
Q3 2022 Nov 14, 2022	BUY	$7.83 - $13.6 $5,238 - $9,098	669 Added 1.51%	44,952 $478,000
Q2 2022 Aug 15, 2022	SELL	$5.04 - $9.26 $1,764 - $3,241	-350 Reduced 0.78%	44,283 $361,000
Q1 2022 May 16, 2022	BUY	$6.16 - $18.03 $7,145 - $20,914	1,160 Added 2.67%	44,633 $320,000
Q4 2021 Feb 14, 2022	BUY	$16.14 - $21.86 $701,654 - $950,319	43,473 New	43,473 $745,000
Q3 2021 Nov 15, 2021	SELL	$19.03 - $41.33 $106,796 - $231,943	-5,612 Closed	0 $0
Q2 2021 Aug 17, 2021	BUY	$18.0 - $37.42 $101,016 - $210,001	5,612 New	5,612 $205,000

Others Institutions Holding RXRX

# of Institutions

286

Shares Held

242M

Call Options Held

1.35M

Put Options Held

2.32M

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.31B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account